/

Electronics & Software

/

Magnolia Medical Technologies

Magnolia Medical Technologies

Magnolia Medical Technologies

Verified Nov 2026

Electronics & Software

·

United States flag

Seattle, Washington

·

Since 2006

Magnolia Medical Technologies, founded in 2006 and headquartered in Seattle, Washington, develops blood culture collection devices and diagnostic solutions for hospitals and clinical laboratories. The company employs 50–100 people and operates in the medical device sector. Its Steripath platform includes an Initial Specimen Diversion Device designed to prevent contamination in sepsis testing and reduce false-positive results.

Magnolia Medical Technologies

Verified Nov 2026

AT A GLANCE

Founded

2006

Headquarters

United States flag

Seattle, Washington

Employees

50-100

Ownership

Magnolia Medical Technologies at a glance

Revenue

$10-50M

Est. band

Employees

50-100

Founded

2006

Headquarters

Seattle, Washington

Industries

Automotive

Electric Vehicles

Medical

Plumbing & Hardware

Industrial Equipment

Overview

Magnolia Medical Technologies, founded in 2006 and headquartered in Seattle, Washington, develops blood culture collection devices and diagnostic solutions for hospitals and clinical laboratories. The company employs 50–100 people and operates in the medical device sector. Its Steripath platform includes an Initial Specimen Diversion Device designed to prevent contamination in sepsis testing and reduce false-positive results.

At a glance

Attribute

Detail

Founded

2006

Headquarters

Seattle, Washington

Employees

50-100

Revenue

$10-50M (estimated)

Primary capability

Electronics & Software

What Magnolia Medical Technologies makes

Magnolia Medical offers the Steripath platform with Initial Specimen Diversion Device technology and Magnolia Analytics, a data service designed to improve diagnostic accuracy in blood culture testing.

Products and capabilities described on the company's own site include LED (source: magnolia-medical.com).

Latest developments

Company details

The company serves hospitals, healthcare systems, and clinical laboratories across the United States, with a focus on reducing misdiagnosis and supporting antimicrobial stewardship programs. Magnolia Medical Technologies was founded in 2006, has an estimated 50-100 employees, and is headquartered in Seattle, Washington.

Frequently asked questions

What does Magnolia Medical Technologies make?

Magnolia Medical Technologies, founded in 2006 and headquartered in Seattle, Washington, develops blood culture collection devices and diagnostic solutions for hospitals and clinical laboratories. The company employs 50–100 people and operates in the medical device sector. Its Steripath platform includes an Initial Specimen Diversion Device designed to prevent contamination in sepsis testing and reduce false-positive results.

Where is Magnolia Medical Technologies headquartered?

Magnolia Medical Technologies is headquartered in Seattle, Washington (220 West Mercer Street, Seattle, Washington, 98119).

When was Magnolia Medical Technologies founded?

Magnolia Medical Technologies was founded in 2006.

How big is Magnolia Medical Technologies?

Magnolia Medical Technologies has an estimated 50-100 employees, with revenue in the $10-50M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Seattle, Washington (HQ)Headquarters · United States
Seattle, Washington (HQ)220 West Mercer Street, Seattle, Washington, 98119, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.